Clinical Trials Browser

Not yet recruiting × Stomach Neoplasms × disitamab vedotin × Clear all

NCT06385873 2024-05-13

RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Stomach Neoplasms